IDEAYA Biosciences, Inc. - Common Stock (IDYA)
CUSIP: 45166A102
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,836,000
- Total 13F shares
- 59,708,967
- Share change
- +3,380,727
- Total reported value
- $1,610,925,530
- Put/Call ratio
- 110%
- Price per share
- $26.98
- Number of holders
- 143
- Value change
- +$91,466,602
- Number of buys
- 79
- Number of sells
- 51
Quarterly Holders Quick Answers
What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45166A102:
Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
6.5%
|
5,683,489
|
$133,561,992 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5%
|
4,355,696
|
$102,358,860 | — | 30 Jun 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
3.9%
|
3,389,698
|
$79,657,903 | — | 30 Jun 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
3.4%
|
2,985,700
|
$70,163,950 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.2%
|
2,829,653
|
$66,496,845 | — | 30 Jun 2023 | |
| Canaan Partners X LLC |
13F
|
Company |
3%
|
2,660,713
|
$62,526,756 | — | 30 Jun 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.9%
|
2,575,110
|
$60,515,085 | — | 30 Jun 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.8%
|
2,502,673
|
$58,814,000 | — | 30 Jun 2023 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.6%
|
2,268,628
|
$53,312,758 | — | 30 Jun 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
2.5%
|
2,202,812
|
$51,766,000 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
2,138,503
|
$50,254,821 | — | 30 Jun 2023 | |
| Logos Global Management LP |
13F
|
Company |
2%
|
1,750,000
|
$41,125,000 | — | 30 Jun 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.9%
|
1,667,523
|
$39,172,672 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.3%
|
1,153,429
|
$27,105,582 | — | 30 Jun 2023 | |
| FMR LLC |
13F
|
Company |
1.2%
|
1,096,898
|
$25,777,103 | — | 30 Jun 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.2%
|
1,086,349
|
$25,528,551 | — | 30 Jun 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.2%
|
1,062,123
|
$24,959,891 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,022,753
|
$24,034,703 | — | 30 Jun 2023 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.93%
|
814,670
|
$19,144,745 | — | 30 Jun 2023 | |
| Commodore Capital LP |
13F
|
Company |
0.88%
|
775,000
|
$18,212,500 | — | 30 Jun 2023 | |
| Capital Research Global Investors |
13F
|
Company |
0.82%
|
723,802
|
$17,009,347 | — | 30 Jun 2023 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.76%
|
664,746
|
$15,621,531 | — | 30 Jun 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.68%
|
600,000
|
$14,100,000 | — | 30 Jun 2023 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.68%
|
593,065
|
$13,937,027 | — | 30 Jun 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.65%
|
567,488
|
$13,335,968 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.62%
|
541,988
|
$12,736,719 | — | 30 Jun 2023 | |
| BOONE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.57%
|
496,433
|
$11,666,176 | — | 30 Jun 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.56%
|
490,893
|
$11,535,987 | — | 30 Jun 2023 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.55%
|
479,820
|
$11,275,770 | — | 30 Jun 2023 | |
| Opaleye Management Inc. |
13F
|
Company |
0.47%
|
415,000
|
$9,752,500 | — | 30 Jun 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.47%
|
410,020
|
$9,635,470 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.44%
|
390,079
|
$9,166,857 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.4%
|
352,566
|
$8,285,303 | — | 30 Jun 2023 | |
| AXA S.A. |
13F
|
Company |
0.39%
|
344,961
|
$8,106,584 | — | 30 Jun 2023 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.32%
|
284,227
|
$6,679,335 | — | 30 Jun 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.31%
|
271,931
|
$6,390,379 | — | 30 Jun 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.3%
|
262,436
|
$6,167,246 | — | 30 Jun 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.28%
|
242,161
|
$5,690,786 | — | 30 Jun 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.27%
|
233,434
|
$5,485,699 | — | 30 Jun 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.26%
|
229,110
|
$5,384,086 | — | 30 Jun 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.25%
|
223,800
|
$5,259,300 | — | 30 Jun 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.24%
|
213,215
|
$5,010,553 | — | 30 Jun 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.2%
|
177,024
|
$4,160,064 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
174,168
|
$4,092,949 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.17%
|
146,116
|
$3,433,726 | — | 30 Jun 2023 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.17%
|
145,860
|
$3,427,710 | — | 30 Jun 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.16%
|
141,149
|
$3,317,002 | — | 30 Jun 2023 | |
| Michael P. Dillon |
3/4/5
|
SVP, Chief Scientific Officer |
—
mixed-class rows
|
102,226
mixed-class rows
|
$3,311,116 | — | 04 Oct 2021 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.14%
|
127,339
|
$2,992,467 | — | 30 Jun 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.14%
|
125,017
|
$2,937,900 | — | 30 Jun 2023 |
Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q3 2023
As of 30 Sep 2023,
IDEAYA Biosciences, Inc. - Common Stock (IDYA) was held by
143 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,708,967 shares.
The largest 10 holders included
BVF INC/IL, BlackRock Inc., FEDERATED HERMES, INC., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Canaan Partners X LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Logos Global Management LP, and Boxer Capital, LLC.
This page lists
143
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
138
Q3 2023 holders
143
Holder diff
5
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.